Meta Biomed Co., Ltd. (KOSDAQ:059210)

Market Cap	160.73B
Revenue (ttm)	99.23B
Net Income (ttm)	22.42B
Shares Out	26.48M
EPS (ttm)	637.11
PE Ratio	9.62
Forward PE	n/a
Dividend	30.00 (0.49%)
Ex-Dividend Date	Dec 27, 2024

Volume	696,211
Average Volume	384,140
Open	5,900.00
Previous Close	5,830.00
Day's Range	5,860.00 - 6,120.00
52-Week Range	3,210.00 - 6,480.00
Beta	0.63
RSI	62.28
Earnings Date	Aug 14, 2025

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux...

• Industry: Dental Equipment and Supplies
• Founded: 1990
• Employees: 288
• Stock Exchange: KOSDAQ
• Ticker Symbol: 059210

Financial Performance

In 2024, Meta Biomed's revenue was 94.04 billion, an increase of 13.16% compared to the previous year's 83.10 billion. Earnings were 22.40 billion, an increase of 122.24%.